None listed
Conditions
Interventions
Others(Electric massage chair) : This study was designed as an open-label, phase 2 clinical trial conducted at the Korea University Anam Hospital. Between June 2020 and July 2021, solid cancer patient
Sponsors
Korea University Anam Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -20 years old or older -Patients with histologically confirmed solid tumors -Patients receiving chemotherapy for the first time in their lives -Patients who are planned to receive HEC/MEC as defined in the NCCN guideline 2019-2020 -ECOG PS 0-2 - defined as having appropriate cardiac and renal function as follows: a. Hemoglobin = 8.0 g/dL b. Absolute neutrophil count = 1.0 x 10^9/L c. Platelet count = 75 x 10^9/L d. Serum bilirubin = 1.5 x ULN e. AST/ALT = 2.5 x ULN f. Creatinine clearance calculated by the Cockcroft-Gault formula > 50 mL/min
Exclusion criteria
Exclusion criteria: -Patients with disseminated/extensive bone metastasis -Patients with serious musculoskeletal diseases or peripheral vascular diseases as determined by the investigator -Patients receiving anticoagulants or antiplatelet drugs -Patients currently using a massager at home -Patients who have undergone major surgery or experienced serious trauma within 2 weeks prior to the study -Participants who use medications that may pose a risk to the participant or interfere with study results, or have medical/psychiatric/social disorders -Patients with medical conditions that may increase the risk or interfere with the interpretation of study results according to the investigator's judgement or abnormal laboratory test results in the testing room.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| INVR | — |
Secondary
| Measure | Time frame |
|---|---|
| complete response rate;EORTC-QLQ-C30 | — |
Countries
Korea, Republic of
Contacts
Public ContactJu Won Kim
Korea University Anam Hospital
Outcome results
None listed